Skip to main content
CELL BIOTECH CO ., LTD logo

CELL BIOTECH CO ., LTD — Investor Relations & Filings

Ticker · 049960 ISIN · KR7049960008 KO Manufacturing
Open in API
Filings indexed 189 across all filing types
Latest filing 2018-11-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 049960

About CELL BIOTECH CO ., LTD

https://www.cellbiotech.com/

CELL BIOTECH CO., LTD. is a biotechnology company specializing in the research, development, and manufacturing of probiotic solutions. With over three decades of experience, the company leverages its proprietary, worldwide-patented dual-coating technology, which is designed to ensure a higher survival rate for probiotic strains as they pass through the gastrointestinal tract. The company develops and utilizes its own GRAS (Generally Recognized as Safe) certified strains for its products. Its business encompasses the production of finished consumer products, such as the DUOLAC brand, and providing customized OEM/ODM services for the pharmaceutical and food supplement sectors.

Recent filings

Filing Released Lang Actions
분기보고서 (2018.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company Cell Biotech (쎌바이오텍) covering the period from January 1, 2018, to September 30, 2018. It contains detailed financial statements, business operations, management analysis, and governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-11-14 Korean
신규시설투자등(자율공시)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure regarding a new facility investment (capital expenditure) by Cell Biotech. It details the investment amount, purpose (factory construction for pharmaceutical manufacturing), and timeline. Since it is a specific corporate announcement regarding capital allocation and infrastructure investment that does not fit into the other specific categories like M&A or share issues, it is classified as a general regulatory filing.
2018-11-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Preliminary Earnings Release' (영업(잠정)실적) for Cell Biotech, detailing quarterly financial performance (revenue, operating profit, net income) for the 3rd quarter of 2018. It provides key financial highlights and explicitly states that these are preliminary figures subject to audit. This fits the definition of an Earnings Release (ER) as it is an initial announcement of periodic financial results. Q3 2018
2018-11-08 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by Cell Biotech. It details the patent name, content, and application plan. Since it does not fit into specific categories like financial reports, M&A, or director dealings, and is a regulatory disclosure of a corporate event, it falls under the general regulatory filing category.
2018-11-01 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by Cell Biotech. It details the patent name, content, holder, and application date. Since this is a specific corporate announcement regarding business operations that does not fit into financial reporting, dividend, or management change categories, it falls under the general regulatory filing category.
2018-11-01 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by Cell Biotech. It details the patent name, content, and utilization plan. Since it does not fit into specific categories like financial reports, board changes, or dividends, and is a regulatory disclosure of a corporate event, it falls under the general regulatory filings category.
2018-11-01 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.